Poliwogg News

SBIO is One of Five ETFs Crushing the Market to Start Q2

Overriding concerns over weak corporate earnings, U.S. stocks hit fresh highs of 2016. This is especially true as conservative earnings estimates are actually setting the stage for positive surprises.

Read More

ETFs to Play a Pop in Biotech M&A

Andrew Peters, an analyst at UBS, says that now might be a good time to load up on small- and mid-cap biotech names as big-caps circle their acquisition wagons...

Read More

SBIO is One of Three ETFs with Bear Killing Magic

The time is ripe for these three biotechnology exchange-traded funds, which are posting robust double-digit gains while the broader markets falter...

Read More

SBIO is a Top Performing ETF of 2015

What was the top-performing ETF of 2015? The answer might surprise you. After all the hoopla surrounding the bursting of China's stock market bubble only a few months ago, it's somewhat ironic that the No. 1-performing ETF on this list is a China fund....

Read More

SBIO is an ETFs Outperformer with 20% Plus Gains Year to Date

It was a tough year for the U.S. markets as most of the major benchmarks are struggling to register healthy gains this year. Several concerns including sluggish global growth, a dramatic slide in oil prices and a stronger dollar continued to hurt the performances of the benchmarks throughout the year. Though many of the ETFs followed the overall trend of the market movement, some of them took recourse to an alternative path...

Read More

SBIO is Top ETF in November

Finally, the U.S. stock market has entered into its strong stretch. Historically, the three months from November through January are the most successful in the stock markets. A consensus carried out from 1950 to 2013 has revealed that November has ended up offering positive returns in 43 years and negative returns in 22 years, with an average return of 1.37%, as per moneychimp.com...

Read More

Poliwogg In the News